Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing

- Burgess, Andrew, Goon, Ken, Brannan, John D., Attia, John, Palazzi, Kerrin, Oldmeadow, Christopher, Corte, Tamera J., Glaspole, Ian, Goh, Nicole, Keir, Gregory, Allan, Heather, Chapman, Sally, Cooper, Wendy, Ellis, Samantha, Hopkins, Peter, Moodley, Yuben, Reynolds, Paul, Zappala, Chris, Macansh, Sacha, Grainge, Cristopher

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

- Jo, Helen E., Glaspole, Ian, Macansh, Sacha, Grainge, Christopher, Keir, Gregory J., Hayen, Andrew, Henderson, Douglas, Klebe, Sonja, Heinze, Stefan B., Miller, Anne, Rouse, Hannah C., Duhig, Edwina, Goh, Nicole, Cooper, Wendy A., Mahar, AM, Ellis, S, McCormack, SR, Ng, B, Godbolt, DB, Corte, TJ, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, Eugene Haydn, Zappala, Christopher, Allan, Heather

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

- Jo, Helen E., Troy, Lauren K., Whitford, Helen, Chapman, Sally, Reynolds, Paul N., Glaspole, Ian, Beatson, David, Jones, Leonie, Hopkins, Peter, Corte, Tamera J., Keir, Gregory, Chambers, Daniel C., Holland, Anne, Goh, Nicole, Wilsher, Margaret, de Boer, Sally, Moodley, Yuben, Grainge, Christopher